Health CanadaType II
Jamp-Rabeprazol 10mg & 20mg: Affected lot contains overweight or underweight Del...
Published: August 20, 2024Recall ID: 75949Category: generalCountry: Canada
Reason for Recall / Hazard
Product safety
Product Description & Identification
Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada.
Affected Products
Jamp-Rabeprazole
Additional Source Details
| Field | Value |
|---|---|
| N I D | 75949 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/jamp-rabeprazol-10mg-20mg-affected-lot-contains-overweight-or-underweight-delayed |
| Issue | Product safety |
| Title | Jamp-Rabeprazol 10mg & 20mg: Affected lot contains overweight or underweight Delayed-Release tablets. |
| Product | Jamp-Rabeprazole |
| Archived | 0 |
| Category | Drugs |
| Last updated | 2024-08-20 |
| Organization | Drugs and health products |
| Recall class | Type II |
| What you should do | Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada. |